Novartis Drug Cosentyx Fails Late-stage Trial for Artery Disease

Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), a condition characterised by inflammation of the...
Reuters Health Information